Osteoarthritis of the Knee
Conditions
Interventions
None listed
Sponsors
SEIKAGAKU CORPORATION
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Nothing.
Exclusion criteria
Exclusion criteria: 1. Subjects for whom the product is contraindicated according to the Instructions For Use or subjects to whom, in any case, the product is administered not in accordance with the Instructions For Use. 2. Subjects with a history of hypersensitivity due to any ingredients of HyLink.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety - Occurrence of adverse events and adverse reactions | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy - Changes from baseline of pain in osteoarthritis (OA) of the knee | — |
Countries
Europe
Contacts
Public ContactTadamasa Kobayashi
SEIKAGAKU CORPORATION Pharmacovigilance Dept.
Outcome results
None listed